
    
      This is a prospective, open label, single arm, intervention study to examine the safety and
      feasibility of water-only fasting to treat hypertensive patients. Additional aims include
      describing mean changes in resting blood pressure as well as markers of cardiovascular health
      and inflammation between baseline and end of fast, end of refeed, and 6-weeks post departure.
    
  